Back
ESC Professional Premium Access

The effect of ziltivekimab on the neutrophil-lymphocyte ratio: analysis from RESCUE

Session: Cardiovascular risk assessment - Biomarkers 2
Topic: Biomarkers
Speaker: Doctor N. Adamstein (Boston, US)
Event: ESC Congress 2022

Congress Presentation

About the speaker

Doctor Nicholas Adamstein

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
0 follower

7 more presentations in this session

High-sensitivity troponin (hs-Tn) for cardiovascular risk prognostication: a systematic review and meta-analysis

Speaker: Doctor M. Sagris (Athens, GR)

Access
Abstract
Slides
Thumbnail

Long-term prognostic value of trimethylamine N-oxide in community-based adults and patients with coronary heart disease

Speaker: Doctor E. Bjornestad (Stavanger, NO)

Access
Abstract
Slides
Thumbnail

Ultra-sensitive troponin-I and incident coronary heart disease, stroke, heart failure, cardiac arrhythmias, arterial aneurysms and venous thromboembolism hospitalizations

Speaker: Professor J. Empana (Paris, FR)

Access
Abstract
Slides
Thumbnail

High-sensitive Troponin T is not associated with the progression of asymptomatic mild to moderate aortic stenosis: a post hoc substudy of the SEAS trial

Speaker: Doctor E. Hadziselimovic (Copenhagen, DK)

Access
Abstract
Slides
Thumbnail

Elevated high-sensitivity C-reactive protein and the risk for cardiovascular events in chronic cardiac disease

Speaker: Professor J. Bergler-Klein (Vienna, AT)

Access
Abstract
Slides
Thumbnail

Access the full session

Cardiovascular risk assessment - Biomarkers 2

Speakers: Doctor N. Adamstein, Doctor M. Sagris, Doctor E. Bjornestad, Professor J. Empana, Doctor E. Hadziselimovic...
Access
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb